ABCL
AbCellera Biologics Inc. NASDAQ Listed Dec 11, 2020$4.82
After hrs
$5.33
+1.72%
Mkt Cap $1.5B
52w Low $1.94
63.0% of range
52w High $6.51
50d MA $3.71
200d MA $4.14
P/E (TTM)
-9.0x
EV/EBITDA
-6.5x
P/B
1.2x
Debt/Equity
0.1x
ROE
-15.1%
P/FCF
-5.9x
RSI (14)
—
ATR (14)
—
Beta
0.85
50d MA
$3.71
200d MA
$4.14
Avg Volume
4.1M
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
2215 Yukon Street · Vancouver, BC V5Y 0A1 · CA
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | AMC | -0.18 | -0.03 | +83.3% | 3.22 | +4.3% | -0.9% | +11.5% | +12.1% | +18.6% | +15.2% | — |
| Nov 6, 2025 | AMC | -0.17 | -0.19 | -11.8% | 4.53 | -16.1% | -13.7% | -11.0% | -11.5% | -12.4% | -20.1% | — |
| Aug 7, 2025 | AMC | -0.17 | -0.12 | +29.4% | 4.24 | +13.7% | +0.2% | +6.1% | +0.7% | +8.0% | +6.1% | — |
| May 8, 2025 | AMC | -0.17 | -0.15 | +11.8% | 2.01 | +2.5% | +1.0% | +2.5% | +4.5% | +2.0% | +0.5% | — |
| Feb 27, 2025 | AMC | -0.15 | -0.11 | +26.7% | 2.92 | -6.8% | -11.3% | -19.2% | -19.9% | -18.2% | -18.5% | — |
| Nov 4, 2024 | AMC | -0.14 | -0.17 | -21.4% | 2.89 | -13.5% | -5.9% | -4.5% | -5.9% | -6.6% | +9.0% | — |
| Aug 6, 2024 | AMC | -0.15 | -0.13 | +13.3% | 2.85 | -3.5% | -7.7% | -2.8% | -6.0% | -7.4% | -6.3% | — |
| May 7, 2024 | AMC | -0.16 | -0.14 | +12.5% | 4.04 | +0.0% | -5.0% | -2.2% | -5.2% | -4.7% | -5.4% | — |
| Feb 20, 2024 | AMC | -0.14 | -0.17 | -21.4% | 5.31 | -1.1% | -9.4% | -8.7% | -8.3% | -6.8% | -3.6% | — |
| Nov 2, 2023 | AMC | -0.14 | -0.10 | +28.6% | 4.43 | -10.4% | +6.1% | +1.0% | -0.7% | -5.6% | -8.8% | — |
| Aug 3, 2023 | AMC | -0.13 | -0.11 | +15.4% | 6.97 | -6.5% | -13.3% | -16.1% | -15.5% | -13.6% | -15.6% | — |
| May 4, 2023 | AMC | -0.12 | -0.14 | -16.7% | 6.61 | -3.0% | -9.4% | -13.6% | -14.4% | -10.9% | -13.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5 | Cantor Fitzgerald | Initiates | Overweight | $7 | $4.59 | $5.05 | +10.0% | +1.5% | +9.8% | +5.0% | — | — |
| Nov 7 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $4.53 | $3.80 | -16.1% | -13.7% | -11.0% | -11.5% | -12.4% | -20.1% |
| Aug 8 | Stifel | Maintains | Buy → Buy | — | $4.24 | $4.82 | +13.7% | +0.2% | +6.1% | +0.7% | +8.0% | +6.1% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $4.01 | $4.01 | +0.0% | +5.7% | -1.7% | +1.2% | -2.7% | +11.7% |
| May 16 | Truist | Maintains | Buy → Buy | — | $2.02 | $2.03 | +0.5% | +0.5% | +0.0% | +3.5% | -1.5% | -1.0% |
| May 9 | Stifel | Maintains | Buy → Buy | — | $2.01 | $2.06 | +2.5% | +1.0% | +2.5% | +4.5% | +2.0% | +0.5% |
| Apr 16 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $2.43 | $2.45 | +0.8% | -1.6% | -0.4% | +0.8% | +3.7% | +4.1% |
| Mar 3 | Benchmark | Maintains | Hold → Hold | — | $2.59 | $2.61 | +0.8% | -8.9% | -9.7% | -7.7% | -8.1% | -10.0% |
| Feb 28 | Stifel | Maintains | Buy → Buy | — | $2.92 | $2.72 | -6.8% | -11.3% | -19.2% | -19.9% | -18.2% | -18.5% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $3.28 | $3.26 | -0.6% | -7.6% | -11.0% | -8.5% | -15.5% | -9.8% |
| Nov 5 | Stifel | Maintains | Buy → Buy | — | $2.89 | $2.50 | -13.5% | -5.9% | -4.5% | -5.9% | -6.6% | +9.0% |
| Aug 20 | Benchmark | Downgrade | Buy → Hold | — | $2.71 | $2.64 | -2.6% | -4.1% | -2.6% | -7.4% | -3.7% | -0.7% |
| Jul 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $2.80 | $2.91 | +3.9% | +11.8% | +11.4% | +14.3% | +24.6% | +20.4% |
| May 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $4.04 | $4.04 | +0.0% | -5.0% | -2.2% | -5.2% | -4.7% | -5.4% |
| Feb 22 | Benchmark | Upgrade | Hold → Buy | — | $4.81 | $5.03 | +4.6% | +0.8% | +1.2% | +2.9% | +6.4% | +5.6% |
| Feb 21 | Stifel | Maintains | Buy → Buy | — | $5.31 | $5.25 | -1.1% | -9.4% | -8.7% | -8.3% | -6.8% | -3.6% |
| Aug 31 | Benchmark | Maintains | Buy → Buy | — | $5.80 | $5.79 | -0.2% | -6.0% | -3.6% | -4.3% | -5.0% | -4.1% |
| Aug 4 | Goldman Sachs | Maintains | Buy → Buy | — | $6.97 | $6.52 | -6.5% | -13.3% | -16.1% | -15.5% | -13.6% | -15.6% |
| May 5 | Credit Suisse | Maintains | Outperform → Outperform | — | $6.61 | $6.41 | -3.0% | -9.4% | -13.6% | -14.4% | -10.9% | -13.2% |
| Feb 28 | Cowen & Co. | Maintains | Outperform → Outperform | — | $8.43 | $8.49 | +0.7% | -0.4% | -3.3% | -3.0% | -0.6% | -3.9% |
| Feb 22 | BMO Capital | Maintains | Outperform → Outperform | — | $8.89 | $8.70 | -2.1% | -1.1% | -4.3% | -5.8% | -5.2% | -5.5% |
| Feb 22 | Credit Suisse | Maintains | Outperform → Outperform | — | $8.89 | $8.70 | -2.1% | -1.1% | -4.3% | -5.8% | -5.2% | -5.5% |
| Jan 6 | SVB Leerink | Maintains | Outperform → Outperform | — | $9.65 | $9.70 | +0.5% | -1.5% | -1.0% | -2.8% | -0.5% | +5.7% |
| Dec 15 | Goldman Sachs | Maintains | Buy → Buy | — | $10.13 | $11.14 | +10.0% | +2.7% | +0.8% | -1.9% | +2.8% | +4.6% |
| Nov 16 | Truist | Maintains | Buy → Buy | — | $14.49 | $14.73 | +1.7% | +0.2% | -2.8% | -2.3% | -3.0% | -3.5% |
| Nov 9 | SVB Leerink | Maintains | Outperform → Outperform | — | $12.24 | $12.99 | +6.1% | -3.5% | +5.5% | +10.9% | +16.6% | +18.4% |
| Aug 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $11.11 | $10.72 | -3.5% | +20.1% | +20.3% | +23.1% | +21.9% | +14.8% |
| Jul 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.10 | $10.11 | +0.1% | +0.9% | +4.1% | +3.3% | -0.6% | +0.4% |
| May 11 | SVB Leerink | Maintains | Outperform → Outperform | — | $6.64 | $6.96 | +4.8% | -13.9% | +1.1% | +8.9% | +17.6% | +22.7% |
| May 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.64 | $6.96 | +4.8% | -13.9% | +1.1% | +8.9% | +17.6% | +22.7% |
| Feb 25 | SVB Leerink | Maintains | Outperform → Outperform | — | $8.45 | $9.36 | +10.8% | +5.7% | +3.1% | +7.0% | +11.6% | +7.0% |
| Feb 25 | Credit Suisse | Maintains | Outperform → Outperform | — | $8.45 | $9.36 | +10.8% | +5.7% | +3.1% | +7.0% | +11.6% | +7.0% |
| Dec 21 | Benchmark | Maintains | Buy → Buy | — | $14.60 | $14.92 | +2.2% | +7.8% | +5.5% | +2.3% | +1.0% | -6.1% |
| Nov 19 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.31 | $15.57 | +1.7% | +3.2% | -5.8% | -8.8% | -5.7% | -8.6% |
| Aug 13 | Credit Suisse | Maintains | Outperform → Outperform | — | $15.19 | $15.00 | -1.3% | +17.8% | +16.3% | +9.2% | +10.3% | +4.0% |
| May 14 | Credit Suisse | Maintains | Outperform → Outperform | — | $34.14 | $31.75 | -7.0% | -7.0% | +0.1% | -3.4% | -5.2% | -6.9% |
| Mar 30 | Stifel | Maintains | Buy → Buy | — | $23.29 | $27.52 | +18.2% | +14.6% | +45.8% | +31.9% | +20.6% | +24.5% |
| Feb 8 | SVB Leerink | Maintains | Outperform → Outperform | — | $46.55 | $49.00 | +5.3% | -3.3% | +1.0% | +0.9% | -1.2% | -7.7% |
| Jan 5 | BMO Capital | Maintains | Outperform → Outperform | — | $39.10 | $38.81 | -0.7% | -1.5% | +1.3% | +0.6% | +1.6% | -6.4% |
No insider trades available.
Data updated apr 24, 2026 10:12am
· Source: massive.com